Advanced Practice Nurses' Use of Prescription Drug Monitoring Program Information

Journal for Nurse Practitioners

Volumn 8, Issue 5, 2012, Pages

  LeMire, Steven D ^a   Martner, Sarah G ^a   Rising, Cheryl ^a,b  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

^b UNIVERSITY OF MARY   (United States)

Author keywords

APN; Drug abuse; Drug diversion; NP; Nurse practitioner; Patient care; PDMP; Prescription drug monitoring program

Indexed keywords

EID: 84860779940     PISSN: 15554155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurpra.2012.02.016     Document Type: Article

References (26)

1. Arria AM, O'Grady KE, Caldeira KM, Vincent KB, Wish ED Nonmedical use of prescription stimulants and analgesics: associations with social and academic behaviors among college students. Pharmacotherapy 2008, 38(4):1045-1060. Accessed October 17, 2011. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906759/.
2. Hamilton GJ Prescription drug abuse. Psychol Schools 2009, 46(9):892-898. Accessed October 17, 2011. http://onlinelibrary.wiley.com/doi/10.1002/pits.20429/pdf.
3. McCabe SE Screening for drug abuse among medical and nonmedical users of prescription drugs in a probability sample of college students. Arch Pediat Adol Med 2008, 162(3):225-231. Accessed October 17, 2011. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2383928/.
4. Quintero G Rx for a party: a qualitative analysis of recreational pharmaceutical use in a collegiate setting. J Am Coll Health 2009, 58(1):64-72. Accessed October 17, 2011. http://www.tandfonline.com/doi/abs/10.3200/JACH.58.1.64-72.
5. Phillips SJ 22nd annual legislative update: regulatory and legislative successes for NPs. Nurs Pract 2010, 35(1):24-47. Accessed October 17, 2011. http://journals.lww.com/tnpj/Citation/2010/01000/22nd_Annual_Legislative_Update_Regulatory__and.8.aspx.
6. Substance Abuse and Mental Health Services Administration Results from the 2006 National Survey on Drug Use and Health: national findings Accessed October 17, 2011. http://www.oas.samhsa.gov/nsduh/2k6nsduh/2k6results.pdf.
7. US Department of Justice, Drug Enforcement Administration, Office of Diversion Control Program description Accessed October 17, 2011. http://www.deadiversion.usdoj.gov/prog_dscrpt/index.html.
8. Advokat CD, Guidry D, Martino L Licit and illicit use of medications for attention-deficit hyperactivity disorder in undergraduate college students. J Am Coll Health 2008, 56(6):601-606. Accessed October 17, 2011. http://www.tandfonline.com/doi/abs/10.3200/JACH.56.6.601-606.
9. Dupont RL, Coleman JJ, Bucher RH, Wilford BB Characteristics and motives of college students who engage in nonmedical use of methylphenidate. Am J Addiction 2008, 17(3):167-171. Accessed October 17, 2011. http://onlinelibrary.wiley.com/doi/10.1080/10550490802019642/pdf.
10. Manchikanti L Prescription drug abuse: what is being done to address this new drug epidemic? Testimony before the subcommittee on criminal justice, drug policy, and human resources. Pain Physician 2006, 9(4):287-321. Accessed October 17, 2011. http://www.painphysicianjournal.com/pastissue_vw.php?jcode=30.
11. Thompson D In U.S., prescription drug abuse is growing. ABC News Web site Accessed October 17, 2011. http://abcnews.go.com/Health/Healthday/us-prescription-drug-abusegrowing/story?id=9443775.
12. Blunk M, Williams K Early identification, treatment, and interventions for the prevention of benzodiazepine dependence with anxiety disorders. Ment Health Subst Use 2011, 4(4):277-292.
13. Licata SC, Rowlett JK Abuse and dependence liability of benzodiazepine-type drugs: GABA receptor modulation and beyond. Pharmacol Biochem Be 2008, 90(1):74-89.
14. Alliance of States with Prescription Monitoring Programs Prescription monitoring frequently asked questions (FAQ) Accessed January 30, 2012. http://www.pmpalliance.org/content/prescription-monitoring-frequently-asked-questions-faq.
15. Alliance of States with Prescription Monitoring Programs The goals of prescription monitoring Accessed October 17, 2011. http://www.pmpalliance.org/pdfs/resourcespdfs/goalsprescripmonitor.pdf.
16. Barrett K, Watson A Physician perspectives on a pilot prescription monitoring program. J Pain Palliat Care Pharmacother 2005, 19(3):5-13. Accessed January 23, 2012. http://informahealthcare.com/doi/abs/10.1080/J354v19n03_03.
17. Feldman L, Williams KS, Coates J, Knox M Awareness and utilization of a prescription monitoring program among physicians. J Pain Palliat Care Pharmacother 2011, 25(4):313-317.
18. Ulbrich TR, Dula CA, Green CG, Porter K, Bennett MS Factors influencing community pharmacists' enrollment in a state prescription monitoring program. J Am Pharm Assoc 2003, 50(5):588-594.
19. Blumenschein K, Fink JL, Freeman PR, Kirsh KL, Steinke DT, Talbert J Independent Evaluation of the Impact and Effectiveness of the Kentucky All Schedule Prescription Electronic Reporting Program (KASPER) 2010, Institute for Pharmaceutical Outcomes and Policy, University of Kentucky, Lexington, KY, Accessed January 23, 2012. http://www.chfs.ky.gov/NR/rdonlyres/24493B2E-B1A1-4399-89AD-1625953BAD43/0/KASPEREvaluationFinalReport10152010.pdf.
20. Lambert D Impact Evaluation of Maine's Prescription Drug Monitoring Program 2007, Muskie School of Public Service, University of Southern Maine, Portland, ME, Accessed January 23, 2012. http://muskie.usm.maine.edu/Publications/ihp/PrescDrugMonitoringPgrmExecSum.pdf.
21. VA Department of Health Professions (VDHP) and VA State Police (VSP) Prescription Monitoring Program: Report of the Virginia Department of Health Professions and Virginia State Police 2004, VDHP and VSP, Richmond, VA, Accessed January 23, 2012. http://www.dhp.state.va.us/dhp_programs/pmp/docs/REPORT%20OF%20THE%20PMP.pdf.
22. Hoffmann DE, Tarzian AJ Achieving the right balance in oversight of physician opioid prescribing for pain: the role of state medical boards. J Law Med Ethics 2003, 31(1):21-40. Accessed November 1, 2011. http://onlinelibrary.wiley.com/doi/10.1111/j.1748-720X.2003.tb00057.x/pdf.
23. Fishman SM, Papazian JS, Gonzalez S, Riches PS, Gilson A Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain. Pain Medicine 2004, 5(3):309-324. Accessed November 1, 2011. http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4637.2004.04049.x/full.
24. Brushwood DB Maximizing the value of electronic prescription monitoring programs. J Law Med Ethics 2003, 31(1):41-54. Accessed October 17, 2011. http://onlinelibrary.wiley.com/doi/10.1111/j.1748-720X.2003.tb00058.x/pdf.
25. Wolfert MZ, Gilson AM, Dahl JL, Cleary JF Opioid analgesics for pain control: Wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practices. Pain Med 2010, 11(3):425-434. Accessed October 17, 2011. http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4637.2009.00761.x/full.
26. American Academy of Nurse Practitioners Standards of Practice for Nurse Practitioners 2010, Office of Health Policy, Washington, DC, Accessed October 17, 2011. http://www.aanp.org/NR/rdonlyres/FE00E81B-FA96-4779-972B-6162F04C309F/0/2010StandardsOfPractice.pdf.